Biopharma companies are embracing pre-use post-sterilization integrity testing in line with stricter GMP requirements.

Particulates can also affect the biomanufacturing, storage, and transportation of high-value final products. These concerns have the potential to disrupt drug manufacture and postpone patients' access ...

Single-use technology will continue to grow, but downstream processing remains the fly in the ointment for overall, or wider, adoption, says Surendra Balekai, senior global product manager-SUT, at ...